Is the execution of the Learningrx General Release considered an admission of liability by any party?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
It is understood and agreed that the settlement evidenced by this Release is a compromise of all claims herein specified, whether past, present or future, that such claims are doubtful and disputed, and that execution of this Release is not to be construed as an admission of liability on the part of any party.
Rather, liability is expressly denied.
Source: Item 22 — CONTRACTS (FDD page 54)
What This Means (2025 FDD)
According to the 2025 Learningrx Franchise Disclosure Document, the execution of the General Release is explicitly not an admission of liability by any party. The FDD states that the settlement evidenced by the release is a compromise of all claims, whether past, present, or future, and that such claims are considered doubtful and disputed.
The document emphasizes that Learningrx expressly denies any liability. This means that by signing the General Release, Learningrx is not acknowledging any fault or responsibility for any claims being released. This clause protects Learningrx from any implication that settling a claim equates to admitting wrongdoing.
This provision is included to ensure that the agreement to release Learningrx from any claims cannot be interpreted against them as an admission of guilt or responsibility. It clarifies that the release is simply a way to resolve disputes and move forward without either party conceding liability. This is a common practice in franchise agreements to protect the franchisor.